[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342156-105":59,"doc-detail-342156-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","role-of-long-non-coding-rna-leucine-rich-repeat-containing-75-a-antisense-rna1-in-the-invasion-and-progression-of-renal-cell-carcinoma","Role of long non-coding RNA leucine-rich repeat containing 75 A-antisense RNA1 in the invasion and progression of renal cell carcinoma","","Long noncoding RNAs (lncRNAs) are central regulators in cancer biology. This study examined how the lncRNA leucine-rich repeat containing 75 A-antisense RNA1 (LRRC75A-AS1) contributes to renal cell carcinoma (RCC) invasion and progression, and assessed its value as a prognostic biomarker. LRRC75A-AS1 was identified via lncRNA microarray and then measured in 212 clear cell RCC patients after nephrectomy. In vitro experiments in RCC cell lines evaluated its function, while interactions involving microRNA-370-5p and ADAMTS5 were explored. LRRC75A-AS1 was upregulated in tumor tissue and its high expression correlated with poor prognosis, including reduced progression-free survival, with knockdown decreasing proliferation and invasion.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-of-long-non-coding-rna-leucine-rich-repeat-containing-75-a-antisense-rna1-in-the-invasion-and-progression-of-renal-cell-carcinoma/342156/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-of-long-non-coding-rna-leucine-rich-repeat-containing-75-a-antisense-rna1-in-the-invasion-and-progression-of-renal-cell-carcinoma/342156.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of studying LRRC75A-AS1 in RCC?","Question",{"text":112,"@type":113},"The study investigated the oncogenic roles of LRRC75A-AS1 in RCC invasion and progression and evaluated whether it could serve as a prognostic biomarker.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was LRRC75A-AS1 evaluated in patients?",{"text":117,"@type":113},"Expression of LRRC75A-AS1 was assessed in 212 clear cell RCC patients who underwent nephrectomy, and associations with clinical outcomes were analyzed.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional effects did LRRC75A-AS1 knockdown have in RCC cells?",{"text":121,"@type":113},"Knockdown of LRRC75A-AS1 in RCC cell lines reduced cell proliferation and invasion, supporting its role in tumorigenesis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342156,1790153320,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","ONCOLOGY REPORTS 53: 11, 2025  \nRole of long non‑coding RNA leucine‑rich repeat containing 75 A‑antisense RNA1 in the invasion and progression of renal cell carcinoma  \nTAKANORI TOKUNAGA 1 , HIROSHI HIRATA 1 , YUKIHIRO HITAKA 1 , NAKANORI FUJII 1 ,  \nKEITA KOBAYASHI 1 , TAKAHIDE HAYANO2,3 , YOSHIYUKI ASAI2‑4 and KOJI SHIRAISHI 1 Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755‑8505, Japan;  \n1  \n2  \nDepartment of Systems Bioinformatics, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755‑8505, Japan; 3  \nThe Division of Systems Medicine and Informatics, Research Institute for Cell Design Medical Science, Yamaguchi University,  \n4  \nUbe, Yamaguchi 755‑8505, Japan; AI Systems Medicine Research and Training Center, Graduate School of Medicine, Yamaguchi University and Yamaguchi University Hospital, Ube, Yamaguchi 755‑8505, Japan  \nReceived July 22, 2024; Accepted September 20, 2024  \nDOI: 10. 3892/or.2024.8844  \nAbstract. Long noncoding RNAs (lncRNAs) serve pivotal roles in cancer biology. The present study investigated the oncogenic roles of lncRNAs in renal cell carcinoma (RCC) and their potential as prognostic biomarkers. The lncRNA leucine‑rich repeat containing 75 A‑antisense RNA1 (LRRC75A‑AS1) was identified through lncRNA microarray as a potential lncRNA that may predict the efficacy of immune checkpoint inhibitor therapy and cancer progression in RCC. The present study subsequently assessed the expression of LRRC75A‑AS1 in 212 patients with clear cell RCC (ccRCC) who underwent nephrectomy, and performed in vitro functional analysis of LRRC75A‑AS1 in RCC cell lines. Additionally, the interactions between LRRC75A‑AS1, microRNA (miR)‑370‑5p and ADAMTS5 were explored. LRRC75A‑AS1 was revealed to be significantly upregulated in ccRCC tissues compared with in adjacent normal tissues, and high LRRC75A‑AS1 expression was associated with poor prognosis, including lower progression‑free survival, in patients with RCC. The knockdown of LRRC75A‑AS1 in RCC cell lines resulted in  \nCorrespondence to: Dr Hiroshi Hirata, Department of Urology, Graduate School of Medicine, Yamaguchi University, 1‑1‑1 Minami‑kogushi, Ube, Yamaguchi 755‑8505, Japan  \nE‑mail: hiro1333@yamaguchi‑[u.ac.jp](u.ac.jp)  \nAbbreviations: ccRCC, clear cell renal cell carcinoma; ceRNA, competing endogenous RNA; ICI, immune checkpoint inhibitor; lncRNA, long non‑coding RNA; miRNA, microRNA; ncRNA, non‑coding RNA; PFS, progression‑free survival; RCC, renal cell carcinoma; si‑NC, small interfering RNA‑negative control; CSCs, cancer stem cells; FFPE, formalin‑fixed paraffin‑embedded; NLR, neutrophil‑to‑lymphocyte ratio  \nKey words: leucine‑rich repeat containing 75 A‑antisense RNA1, microRNA‑370‑5p, renal cancer, RCC, lncRNA  \nreduced cell proliferation and invasion, highlighting its role in promoting tumorigenesis. Furthermore, the interaction among LRRC75A‑AS1, miR‑370‑5p and ADAMTS5 was suggested as a regulatory mechanism underlying RCC progression . These findings indicated that LRRC75A‑AS1 may func‑ tion as an oncogene in RCC, promoting cell proliferation and invasion. Its significant upregulation in ccRCC tissues and association with poor prognosis underscore its poten‑ tial as a prognostic biomarker for RCC. Understanding the regulatory interactions among LRRC75A‑AS1, miR‑370‑5p and ADAMTS5 may provide new insights into the molecular mechanisms underlying RCC and facilitate the identification of novel therapeutic targets.  \nIntroduction  \nRenal cell carcinoma (RCC) is a renal malignancy originating from the epithelium of the renal tubules of nephrons, which accounts for 2‑3% of adult malignancies and 80‑90% of adult renal malignancies globally (1,2) . RCC is often asymptomatic until its advanced stages, with ~30% of patients diagnosed atthe metastatic stage (3). Despite being the third most common urogenital malignancy after prostate and bladder cancer, RCChas a high mortality rate (4), and its incidence","cbCaioShTVnSgQ9f","https://ap.wps.com/l/cbCaioShTVnSgQ9f","pdf",1814296,"English","# Abstract\n# Introduction","[{\"question\":\"What was the purpose of studying LRRC75A-AS1 in RCC?\",\"answer\":\"The study investigated the oncogenic roles of LRRC75A-AS1 in RCC invasion and progression and evaluated whether it could serve as a prognostic biomarker.\"},{\"question\":\"How was LRRC75A-AS1 evaluated in patients?\",\"answer\":\"Expression of LRRC75A-AS1 was assessed in 212 clear cell RCC patients who underwent nephrectomy, and associations with clinical outcomes were analyzed.\"},{\"question\":\"What functional effects did LRRC75A-AS1 knockdown have in RCC cells?\",\"answer\":\"Knockdown of LRRC75A-AS1 in RCC cell lines reduced cell proliferation and invasion, supporting its role in tumorigenesis.\"}]","Role of long non-coding RNA leucine-rich repeat containing 75 A-antisense RNA1 in the invasion and progression of renal cell carcinoma | PDF",1790045555,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/867c205b9e15125833ae5a30ef962a0c.webp",983,1357,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7269083d297eabadf2bae895a0c7a2b6.webp",982,1356,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e4c6729fac92ebcc12b8aaa175f8f8b.webp",981,1354,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10d1715cfd7b644e392b431446b1f9d3.webp",980,1353]